High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission. [electronic resource]
Producer: 19990303Description: 2671-5 p. digitalISSN:- 1078-0432
- Acute Disease
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow Transplantation
- Busulfan -- administration & dosage
- Child
- Child, Preschool
- Cyclophosphamide -- administration & dosage
- Cyclosporine -- therapeutic use
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Graft vs Host Disease -- prevention & control
- Humans
- Immunosuppressive Agents -- therapeutic use
- Leukemia, Myeloid -- drug therapy
- Male
- Methotrexate -- therapeutic use
- Methylprednisolone -- therapeutic use
- Middle Aged
- Remission Induction
- Time Factors
- Transplantation, Homologous
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.